标题
CMV-specific immune reconstitution following allogeneic stem cell transplantation
作者
关键词
-
出版物
Virulence
Volume 7, Issue 8, Pages 967-980
出版商
Informa UK Limited
发表日期
2016-08-10
DOI
10.1080/21505594.2016.1221022
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
- (2016) P. Teira et al. BLOOD
- Impact of early CMV reactivation in cord blood stem cell recipients in the current era
- (2016) M Ramanathan et al. BONE MARROW TRANSPLANTATION
- TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
- (2016) M Maschan et al. BONE MARROW TRANSPLANTATION
- Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8+T cell receptor alpha repertoire following allogeneic transplantation
- (2016) C. S. Link et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation
- (2016) Ondřej Pelák et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity
- (2016) Marco Herling et al. JOURNAL OF CLINICAL VIROLOGY
- Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
- (2016) Ryotaro Nakamura et al. Lancet Haematology
- Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- (2016) Margaret L Green et al. Lancet Haematology
- Platelet secretion paves the way
- (2015) Y. Huang et al. BLOOD
- CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire
- (2015) Yvonne Suessmuth et al. BLOOD
- Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall
- (2015) M Noviello et al. BONE MARROW TRANSPLANTATION
- Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?
- (2015) A E Harris et al. BONE MARROW TRANSPLANTATION
- Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies
- (2015) B M Triplett et al. BONE MARROW TRANSPLANTATION
- Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
- (2015) Marie Bleakley et al. JOURNAL OF CLINICAL INVESTIGATION
- Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory
- (2015) Giacomo Oliveira et al. Science Translational Medicine
- Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation
- (2015) E. Giménez et al. Transplant Infectious Disease
- Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia
- (2014) Ji Eun Jang et al. ANNALS OF HEMATOLOGY
- CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status
- (2014) R. S. Sellar et al. BLOOD
- Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
- (2014) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches
- (2014) Natasha A. Jain et al. CYTOTHERAPY
- Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation
- (2014) R. Itzykson et al. HAEMATOLOGICA
- Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes
- (2014) Isabel Corrales et al. JOURNAL OF MEDICAL VIROLOGY
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor Cell Products Ex Vivo and Safely Transferred to Stem Cell Transplantation Recipients to Facilitate Immune Reconstitution
- (2013) Leighton E. Clancy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion
- (2013) S. Stevanovi et al. BLOOD
- CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
- (2013) M. Schmidt-Hieber et al. BLOOD
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
- (2013) E. Blyth et al. BLOOD
- Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
- (2013) A. M. Leen et al. BLOOD
- Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes
- (2013) H W Xiao et al. BONE MARROW TRANSPLANTATION
- CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
- (2013) S Ito et al. BONE MARROW TRANSPLANTATION
- Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients
- (2013) Dayana Bravo et al. JOURNAL OF MEDICAL VIROLOGY
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications
- (2013) Siok-Keen Tey et al. PLoS One
- Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
- (2012) Margaret L. Green et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
- (2012) L. Vago et al. BLOOD
- Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8+T-Cell Response in Allogeneic Stem Cell Transplant Recipients
- (2012) María Ángeles Clari et al. Clinical and Vaccine Immunology
- Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
- (2012) M. Uhlin et al. CLINICAL INFECTIOUS DISEASES
- A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2012) Mohamed A Kharfan-Dabaja et al. LANCET INFECTIOUS DISEASES
- Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Daniele Lilleri et al. PLoS One
- Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation
- (2011) Abraham Guerrero et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia
- (2011) M. Montillo et al. BLOOD
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
- (2011) Nicolas Goardon et al. CANCER CELL
- Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- (2011) Per Ljungman et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients
- (2011) Beatriz Muñoz-Cobo et al. JOURNAL OF MEDICAL VIROLOGY
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
- (2011) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME)
- (2011) Thomas Thiele et al. TRANSFUSION
- Antibody Treatment Promotes Compensation for Human Cytomegalovirus-Induced Pathogenesis and a Hypoxia-Like Condition in Placentas with Congenital Infection
- (2010) Ekaterina Maidji et al. AMERICAN JOURNAL OF PATHOLOGY
- Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) Xiao-Hua Luo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
- (2010) X. Wang et al. BLOOD
- The role of V 2-negative T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation
- (2010) A. Knight et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
- (2010) K. S. Peggs et al. CLINICAL INFECTIOUS DISEASES
- A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells
- (2010) C. Berger et al. JOURNAL OF MEDICAL PRIMATOLOGY
- Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: Potential implications for the management of active CMV infection
- (2010) Nuria Tormo et al. JOURNAL OF MEDICAL VIROLOGY
- Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy
- (2009) Carolyn E. Behrendt et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
- (2009) P. Scheinberg et al. BLOOD
- Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients
- (2009) N Tormo et al. BONE MARROW TRANSPLANTATION
- CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study
- (2009) Fredrik Sund et al. CLINICAL TRANSPLANTATION
- Adoptive T cell immunotherapy for cytomegalovirus
- (2009) Karl S Peggs EXPERT OPINION ON BIOLOGICAL THERAPY
- Findings and conclusions from CMV hyperimmune globulin treatment trials
- (2009) Stuart P. Adler et al. JOURNAL OF CLINICAL VIROLOGY
- Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation
- (2008) K. P. Micklethwaite et al. BLOOD
- Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation
- (2008) M. Mezger et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft
- (2008) Jan Storek EXPERT OPINION ON BIOLOGICAL THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More